Literature DB >> 21177699

Estimating modifiable coronary heart disease risk in multiple regions of the world: the INTERHEART Modifiable Risk Score.

Catherine McGorrian1, Salim Yusuf, Shofiqul Islam, Hyejung Jung, Sumathy Rangarajan, Alvaro Avezum, Dorairaj Prabhakaran, Wael Almahmeed, Zvonko Rumboldt, Andrzej Budaj, Antonio L Dans, Hertzel C Gerstein, Koon Teo, Sonia S Anand.   

Abstract

AIMS: Summating risk factor burden is a useful approach in the assessment of cardiovascular risk among apparently healthy individuals. We aimed to derive and validate a new score for myocardial infarction (MI) risk using modifiable risk factors, derived from the INTERHEART case-control study (n = 19 470). METHODS AND
RESULTS: Multiple logistic regression was used to create the INTERHEART Modifiable Risk Score (IHMRS). Internal validation was performed using split-sample methods. External validation was performed in an international prospective cohort study. A risk model including apolipoproteins, smoking, second-hand smoke exposure, hypertension, and diabetes was developed. Addition of further modifiable risk factors did not improve score discrimination in an external cohort. Split-sample validation studies showed an area under the receiver-operating characteristic (ROC) curve c-statistic of 0.71 [95% confidence interval (CI): 0.70, 0.72]. The IHMRS was positively associated with incident MI in a large cohort of people at low risk for cardiovascular disease [12% increase in MI risk (95% CI: 8, 16%) with a 1-point increase in score] and showed appropriate discrimination in this cohort (ROC c-statistic 0.69, 95% CI: 0.64, 0.74). Results were consistent across ethnic groups and geographic regions. A non-laboratory-based score is also supplied.
CONCLUSIONS: Using multiple modifiable risk factors from the INTERHEART case-control study, we have developed and validated a simple score for MI risk which is applicable to an international population.

Entities:  

Mesh:

Year:  2010        PMID: 21177699     DOI: 10.1093/eurheartj/ehq448

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  76 in total

1.  Blood Pressure Levels at the Time of Percutaneous Coronary Revascularization and Risk of Coronary In-Stent Restenosis.

Authors:  Giuliano Tocci; Emanuele Barbato; Roberta Coluccia; Anna Modestino; Beniamino Pagliaro; Vittoria Mastromarino; Francesca Giovannelli; Andrea Berni; Massimo Volpe
Journal:  Am J Hypertens       Date:  2015-08-13       Impact factor: 2.689

2.  Exploring New Options for Cardiovascular Disease Prevention May Improve Patients' Quality of Life and Outcomes.

Authors:  Giuliano Tocci; Roberto Pontremoli
Journal:  High Blood Press Cardiovasc Prev       Date:  2016-05-09

3.  Risk-factor profile, drug usage and cardiovascular events within a year in patients with and at high risk of atherothrombosis recruited from Asia as compared with those recruited from non-Asian regions: a substudy of the REduction of Atherothrombosis for Continued Health (REACH) registry.

Authors:  S Goto; Y Ikeda; J C N Chan; P W F Wilson; T Cheng Yeo; C S Liau; M T Abola; G Salette; P G Steg; D L Bhatt
Journal:  Heart Asia       Date:  2011-01-01

4.  Nonclinical Features in Predictive Modeling of Cardiovascular Diseases: A Machine Learning Approach.

Authors:  Mirza Rizwan Sajid; Noryanti Muhammad; Roslinazairimah Zakaria; Ahmad Shahbaz; Syed Ahmad Chan Bukhari; Seifedine Kadry; A Suresh
Journal:  Interdiscip Sci       Date:  2021-03-06       Impact factor: 2.233

5.  Positive Psychology in Lifestyle Medicine and Health Care: Strategies for Implementation.

Authors:  Liana S Lianov; Barbara L Fredrickson; Carrie Barron; Janani Krishnaswami; Anne Wallace
Journal:  Am J Lifestyle Med       Date:  2019-04-18

6.  Ideal cardiovascular health predicts lower risks of myocardial infarction, stroke, and vascular death across whites, blacks, and hispanics: the northern Manhattan study.

Authors:  Chuanhui Dong; Tatjana Rundek; Clinton B Wright; Zane Anwar; Mitchell S V Elkind; Ralph L Sacco
Journal:  Circulation       Date:  2012-05-22       Impact factor: 29.690

7.  Polypill with or without Aspirin in Persons without Cardiovascular Disease.

Authors:  Salim Yusuf; Philip Joseph; Antonio Dans; Peggy Gao; Koon Teo; Denis Xavier; Patricio López-Jaramillo; Khalid Yusoff; Anwar Santoso; Habib Gamra; Shamim Talukder; Courtney Christou; Preeti Girish; Karen Yeates; Freeda Xavier; Gilles Dagenais; Catalina Rocha; Tara McCready; Jessica Tyrwhitt; Jackie Bosch; Prem Pais
Journal:  N Engl J Med       Date:  2020-11-13       Impact factor: 91.245

Review 8.  Dyslipidemias and Cardiovascular Prevention: Tailoring Treatment According to Lipid Phenotype.

Authors:  Veronika Sanin; Vanessa Pfetsch; Wolfgang Koenig
Journal:  Curr Cardiol Rep       Date:  2017-07       Impact factor: 2.931

9.  Impact of β-thalassemia trait carrier state on cardiovascular risk factors and metabolic profile in patients with newly diagnosed hypertension.

Authors:  A I Triantafyllou; G P Vyssoulis; E A Karpanou; P L Karkalousos; E A Triantafyllou; A Aessopos; D T Farmakis
Journal:  J Hum Hypertens       Date:  2013-10-24       Impact factor: 3.012

10.  The effect of quitting smoking on costs and healthcare utilization in patients with chronic obstructive pulmonary disease: a comparison of current smokers versus ex-smokers in routine clinical practice.

Authors:  Antoni Sicras-Mainar; Javier Rejas-Gutiérrez; Ruth Navarro-Artieda; Jordi Ibáñez-Nolla
Journal:  Lung       Date:  2014-05-10       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.